ACAM2000®

ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) is a live, vaccinia virus smallpox vaccine licensed in the U.S. by the Food and Drug Administration for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection. It was developed under a contract with the U.S. Centers for Disease Control and Prevention (CDC).

Notify me on updates of this product 

Availability: Commercially Available

Rebecca Fish
Vice President of Marketing & Product Strategy
fishr@ebsi.com
+1 240 631 3200
400 Professional Drive, Suite 400
Gaithersburg, MD 20879
USA
www.emergentbiosolutions.com/our-products
Manufacturer
Emergent BioSolutions, Inc.
Product Name
ACAM2000®
Detection Category
Biological
Application
Personal Protective Equipment;
Equipment Type
PPE
Product Synopsis
ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) is a live, vaccinia virus smallpox vaccine licensed in the U.S. by the Food and Drug Administration for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection. It was developed under a contract with the U.S. Centers for Disease Control and Prevention (CDC).
Availability
Commercially Available
Technology Readiness Level (TRL)
9
User Feedback Sources
Indifferent/No user feedback
Supporting Documentation
Docs: Acam2000 Product Sheet.pdf;
Weight
<1 lb.
Power Requirements
None
Transportability
Pocket Size
Live Agent Tested
Yes; smallpox
Operating Time
Preventative administration prior to exposure
Standards Met
FDA
Tested By
CDC
Training Required
<1 hour training
Training Available
Yes
Manuals Available
Yes
Please enter contact info.
Email Address: 
Company: 
Name: 
Title: